Gemtesa 75 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FBFW4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,242
Award facts
- Contract value 100% obligated
- $31,241.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $31,241.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 90-count tablets of Gemtesa 75 mg, with an ultimate completion date of December 11, 2025. This is a non-set-aside competitive award issued to the prime contractor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999.999 billion value through December 2026 and serves as a comprehensive global pharmaceutical support vehicle.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical federal vendor for military and veteran healthcare systems. As a prime contractor under the DLA's pharmaceutical procurement framework, the company supplies a comprehensive range of medications, medical devices, and healthcare commodities to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This award for Gemtesa, a medication used to treat overactive bladder, exemplifies the company's role in fulfilling federal medical supply needs through competitively awarded delivery orders with firm fixed pricing across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FBFW4?
SPE2DR26FBFW4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26FBFW4 worth?
The government has obligated $31,242 on SPE2DR26FBFW4.
Is contract SPE2DR26FBFW4 an order under another contract?
Yes. SPE2DR26FBFW4 is a delivery order under SPE2DR25D2001, an indefinite delivery contract.
Was contract SPE2DR26FBFW4 competed?
The extent of competition for SPE2DR26FBFW4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award